Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37538
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHodges R.J.en
dc.contributor.authorHobson S.R.en
dc.contributor.authorWallace E.M.en
dc.contributor.authorKingdom J.C.en
dc.date.accessioned2021-05-14T12:46:34Zen
dc.date.available2021-05-14T12:46:34Zen
dc.date.created20171214en
dc.date.issued2018en
dc.identifier.citationMethods in Molecular Biology. 1710 (pp 347-352), 2018. Date of Publication: 2018.en
dc.identifier.issn1064-3745en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/37538en
dc.description.abstractThis chapter describes the methodologies which may be used in the development of a randomized controlled trial investigating a therapy of choice in preventing preeclampsia.Copyright © 2018, Springer Science+Business Media LLC.en
dc.languageenen
dc.languageEnglishen
dc.publisherHumana Press Inc. (E-mail: humana@humanapr.com)en
dc.relation.ispartofMethods in Molecular Biologyen
dc.titleA randomized double-blinded placebo-controlled intervention trial of melatonin for the prevention of preeclampsia in moderate- and high-risk women: The MELPOP trial.en
dc.typeChapteren
dc.typeChapter-
dc.identifier.affiliationObstetrics and Gynaecology (Monash Women's)-
dc.type.studyortrialRandomised controlled trial-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/978-1-4939-7498-6_28en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid29197017 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29197017]en
dc.identifier.source619560493en
dc.identifier.institution(Hobson, Wallace, Hodges) Maternal Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash Health and Monash University, 246 Clayton Road, Clayton, VIC 3168, Australia (Kingdom) Maternal Fetal Medicine Division, Department of Obstetrics and Gynaecology, Mount Sinai Hospital and University of Toronto, 600 University Avenue, Toronto, ON M5G 1X5, Canadaen
dc.description.addressS.R. Hobson, Maternal Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash Health and Monash University, 246 Clayton Road, Clayton, VIC 3168, Australia. E-mail: sebastian.hobson@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2018 Elsevier B.V., All rights reserved.en
dc.subect.keywordsClinical trial Melatonin Oxidative stress Preeclampsia Preventionen
dc.identifier.authoremailHobson S.R.; sebastian.hobson@monash.eduen
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.cerifentitytypePublications-
item.openairetypeChapter-
item.openairetypeChapter-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptObstetrics and Gynaecology (Monash Women's)-
Appears in Collections:Books and Book Chapters
Show simple item record

Page view(s)

90
checked on Oct 5, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.